FORM SCHEDULE 13D

Company

NEUROCRINE BIOSCIENCES INC

Filed

June 10, 1996

Accession Number

0000950123-96-002943

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →